Abstract | BACKGROUND/AIM: MATERIALS AND METHODS: RESULTS: Administration of Fx in the diet for 5 weeks significantly suppressed the number of colorectal adenocarcinomas in DSS-treated male ApcMin/+ mice, although the treatment did not affect the occurrence of colorectal dysplastic crypts and adenoma in the mice. In addition, Fx down-regulated cyclin D1 expression (0.6-fold) in colorectal mucosa of ApcMin/+ mice when compared with that of the control mice. CONCLUSION: Fx possesses chemopreventive potential against progression of colorectal carcinogenesis in ApcMin/+ mice that receive inflammatory stimuli.
|
Authors | Masaru Terasaki, Takahiro Hamoya, Atsuhito Kubota, Hiroyuki Kojima, Takuji Tanaka, Hayato Maeda, Kazuo Miyashita, Michihiro Mutoh |
Journal | Anticancer research
(Anticancer Res)
Vol. 41
Issue 3
Pg. 1299-1305
(Mar 2021)
ISSN: 1791-7530 [Electronic] Greece |
PMID | 33788721
(Publication Type: Journal Article)
|
Copyright | Copyright © 2021 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved. |
Chemical References |
- Anticarcinogenic Agents
- Ccnd1 protein, mouse
- Xanthophylls
- fucoxanthin
- Cyclin D1
- Dextran Sulfate
|
Topics |
- Adenomatous Polyposis Coli
(complications)
- Animals
- Anticarcinogenic Agents
(administration & dosage)
- Colorectal Neoplasms
(chemically induced, prevention & control)
- Cyclin D1
(analysis, physiology)
- Dextran Sulfate
- Disease Models, Animal
- Male
- Mice
- Xanthophylls
(administration & dosage)
|